Immediate Impact

3 from Science/Nature 69 standout
Sub-graph 1 of 18

Citing Papers

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
3 intermediate papers

Works of Lara Dimick‐Santos being referenced

Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemic
2017
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
2017

Author Peers

Author Last Decade Papers Cites
Lara Dimick‐Santos 483 277 70 171 11 571
Marianna Tarantino 373 173 40 128 9 487
M. Trappoliere 277 132 126 115 9 479
Naga P. Chalasani 358 210 224 132 8 569
GC Farrell 356 133 94 151 6 491
Yoshitaka Nabeshima 464 166 37 310 10 645
Marcos Pasarín 355 237 55 115 9 465
María Valeria Razori 410 113 66 118 10 610
N. Verthier 241 146 74 104 13 577
Kshaunish Das 469 251 20 198 11 520
Vignan Manne 472 315 21 129 25 621

All Works

Loading papers...

Rankless by CCL
2026